u 88204 has been researched along with atevirdine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Althaus, IW; Biles, C; Busso, M; Genin, MJ; Morge, RA; Resnick, L; Reusser, F; Romero, DL; Tarpley, WG; Thomas, RC | 1 |
| Battista, C; Cook, J; Lane, HC; Palmer, JR; Psallidopoulos, MC; Romero, DL; Salzman, NP; Tarpley, WG; Vasudevachari, MB; Zhao, B | 1 |
2 other study(ies) available for u 88204 and atevirdine
| Article | Year |
|---|---|
Bis(heteroaryl)piperazine (BHAP) reverse transcriptase inhibitors: structure-activity relationships of novel substituted indole analogues and the identification of 1-[(5-methanesulfonamido-1H-indol-2-yl)-carbonyl]-4-[3- [(1-methylethyl)amino]-pyridinyl]pi
Topics: Antiviral Agents; Delavirdine; Indoles; Piperazines; Reverse Transcriptase Inhibitors; Structure-Activity Relationship; Virus Replication | 1993 |
Prevention of the spread of HIV-1 infection with nonnucleoside reverse transcriptase inhibitors.
Topics: Cell Line; Drug Resistance, Microbial; HIV Infections; HIV Reverse Transcriptase; HIV-1; Humans; Indoles; Piperazines; Reverse Transcriptase Inhibitors; Viral Proteins; Virus Replication | 1992 |